Replies to post #7125 on Momenta Pharmaceuticals, Inc. (MNTA)

[tekcor_atnm]

Jbog,

Don't hate the player, hate the game. Besides, the market is wide open for an unlimited amount of competitors. All they have to do is come up with their own unique way of proving sameness of their drug like MNTA did, and not infringe on another's patents like Amphastar did .

BTW, the balloon is being re-inflated. Too bad you sold into the strength below $12. Looks like that was the wrong move. What's your next move? Buy some TEVA?

[iwfal]

I certainly wouldn't think her idea is to just create numerous duopolies for each drug which again would be saddled by a patent term. The ink's not dry on any paperwork, either from the FDA or HHS, and I'm pretty sure it'll be looked at.

As I have noted repeatedly - these duopolies are not likely to be long lasting (relative to patent duration). Or even compared to FDA biogeneric FDA approval timelines (e.g. 8 years for aL). So she needn't worry.